thanks for feedback. what bothers me is that i see nothing really compelling and fear we may see devastating bear sometime in next year or two. i'm over 70% cash and may go much more. by compelling i remember buying GNW at a little over a buck in 2009, it dipped below a buck before big run. i dont see those opportunities today.
gap up, possible run over time to upper BB or beyond - good exit point for traders. the developments are positive, look for thread to get very bullish - a good contrarian indicator. but it will take time to realize potentiial. i have a ton of shares - will only trade a portion. i expect them to use ATM on this pop. wild card is big pharma from which new CEO comes. i just hope she comes to realization that the key for SNTA is licensing rather than building a sales force. Licensing the world including US will attract partner - geographical segmentation (current approach) has not.
oubobcat - i didnt intend to cause anger typical shareholder meeting involves reporting on proxy vote, possible CEO address and Q&A. the latter can be used as long as they questions are asked in person. a more effective way of answering individual questions is direct contact with company
Nibbling on XGTI again. It looks like they may do an offering soon. They have history of inflating stock before offering allowing institutions to arbitrage.
As we are time constrained during the Q&A portion of the CC, I would appreciate answers/comments to the following:
1. Would like to see much faster track for the HDCs as their science indicates they would be much more effective the either ganetespib alone or ganetespib in conjunction with chemo. This leads to the following question
2. Partnering - I strongly suspect the obstacle is SNTA insistence on geographical segmentation with SNTA keeping the US market. A better approach would be to draw upon SNTA's technology strength and big Pharma's marketing strength. Such an approach would lead to upfront payment, milestone payments and royalties upon commercialization with Big Pharma getting the world and SNTA collecting healthy royalties and plowing money back into technology (eg the HDCs)
what does Frost see in this. Right now it looks like a shell with tiny profits (royalties) selling for almost 2 x cash. Yet he buys and has a good track record.
His investments have done well. He has been buying CDOM recently. Its selling for about 2 x cash, and very high P/E with about 200 M shares outstanding. It collects royalties on a business it sold. Somehow Frost thinks there is more to it. I also notice a SNTA bear on its thread - makes me wonder whether about whether his real motivation is getting stock into his buy zone
Good post with exception of Fishy comment. MNKD went up from 2's to 10 while it had ATM . The wild card is big pharma. It can change picture instantaneously.